Cellectar Biosciences Growth Metrics (2009-2014) | CLRB

Growth Metrics Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014
Growth Ratios
EBITDA Margin Growth (1y) -2.34M-0.48M0.59M-2.59M2.87M-1.29M-0.36M-0.51M
EBITDA Margin Growth (3y) -4.24M-2.16M
EBITDA Margin (QoQ) 0.08M-1.04M4.28M-5.66M1.94M0.03M1.10M-0.20M
EBIT Margin Growth (1y) -2.34M-0.48M0.59M-2.59M2.87M-1.29M-0.36M-0.51M
EBIT Margin Growth (3y) -4.24M-2.16M
EBIT Margin (QoQ) 0.08M-1.04M4.28M-5.66M1.94M0.03M1.10M-0.20M
EBT Margin Growth (1y) -2.34M-0.48M0.59M-2.62M2.83M-1.28M-0.36M-0.51M
EBT Margin Growth (3y) -4.25M-2.14M
EBT Margin (QoQ) 0.08M-1.04M4.28M-5.66M1.94M0.03M1.07M-0.21M
Enterprise Value Growth (1y) 19.54%76.64%93.03%31.26%94.68%-215.68%-310.02%-725.39%-1,168.16%-115.68%-251.89%14.90%-109.04%17.68%7.72%47.74%51.21%71.43%-125.17%
Enterprise Value Growth (3y) 18.41%-16.73%-0.18%-69.02%-12.16%-77.64%-137.01%-54.26%-134.74%20.24%-94.09%
Enterprise Value Growth (5y) 11.14%17.85%-15.88%
Enterprise Value (QoQ) 35.58%-23.90%82.39%-472.55%81.30%63.04%-73.66%55.67%-1,009.40%51.99%-249.58%31.89%-88.68%21.67%15.46%-67.30%25.69%12.20%52.12%-56.18%56.48%-591.90%
FCF Margin Growth (1y) -2.85M1.57M0.99M-1.64M3.91M-1.25M-0.27M-0.38M
FCF Margin Growth (3y) -3.16M-1.90M
FCF Margin (QoQ) 0.37M-0.97M3.37M-5.61M4.78M-1.55M0.74M-0.07M
Net Margin Growth (1y) 4.57M4.19M-5.49M9.02M-5.86M0.66M-1.59M-0.44M
Net Margin Growth (3y) 8.09M-1.37M
Net Margin (QoQ) -2.84M4.39M-12.37M15.39M-3.22M-5.29M2.13M0.51M
Operating Margin Growth (1y) -2.34M-0.48M0.59M-2.59M2.87M-1.29M-0.36M-0.51M
Operating Margin Growth (3y) -4.24M-2.16M
Operating Margin (QoQ) 0.08M-1.04M4.28M-5.66M1.94M0.03M1.10M-0.20M
Return on Assets Growth (1y) 76.00-87.00-106.0022.0034.00102.00154.00-309.00-292.00-271.00-269.00-7.0033.009.00-104.00-313.00-459.00-480.00-68.00
Return on Assets Growth (3y) -181.00-257.00-221.00-294.00-225.00-160.00-219.00-629.00-718.00-742.00-441.00
Return on Assets Growth (5y) -607.00-727.00-393.00
Return on Assets (QoQ) 104.00-8.00-13.00-6.00-59.00-27.00115.006.008.0025.00-348.0023.0028.0028.00-86.0062.005.00-86.00-295.00-83.00-16.00326.00
Return on Capital Employed Growth (1y) -0.00M597.00-159.00-237.00605.00-0.00M-347.00-309.00-315.00-304.00-298.00-18.00-331.00-274.00-408.00-0.00M-0.00M
Return on Capital Employed Growth (3y) -0.00M-969.00-804.00-565.00-41.00-0.00M-0.00M-0.00M-0.00M
Return on Capital Employed Growth (5y) -0.00M
Return on Capital Employed (QoQ) -0.00M-137.00-332.00-812.000.00M-894.00-409.0030.0011.0021.00-371.0024.0023.0028.00-92.00-289.0079.00-106.00-866.00-377.00
Return on Equity Growth (1y) -301.00-6.00-97.00-343.00-600.00-0.00M-0.01M0.00M-531.00
Return on Equity Growth (3y) -0.00M
Return on Equity (QoQ) -396.0032.0032.0031.00-101.00-59.00-214.00-226.00-0.00M-0.01M0.02M-0.01M
Return on Sales Growth (1y) -0.02M-0.00M0.01M-0.03M0.03M0.01M0.01M-0.01M-0.01M-0.01M-0.01M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.00M-0.00M
Return on Sales Growth (3y) -0.01M-0.01M0.00M-0.04M0.01M-0.01M-0.01M-0.02M-0.02M-0.02M-0.02M
Return on Sales Growth (5y) -0.02M-0.02M-0.01M
Return on Sales (QoQ) 811.00-0.01M0.04M-0.06M0.02M288.000.01M-0.00M156.00-538.00-0.01M-0.00M127.00-59.00-886.00-0.00M-209.00-350.00-0.00M-0.00M0.00M0.00M